Cancer affects millions of people each year – not only those who are diagnosed, but also families, friends, and communities. How can we help give people a better chance at beating cancer? Early detection. It can make all the difference. The sooner cancer is found, the quicker curative treatment can begin.
Find out how those who live with and work with cancer are rewriting the narrative in a brand-new digital series presented by Union for International Cancer Control and produced for them by BBC StoryWorks Commercial Productions.
The series explores innovative solutions for cancer prevention, diagnosis, treatment and care, and spotlights DeepHealth’s role in transforming lung cancer screening.
and
are now
a
company
Empowering breakthroughs in care by unlocking the value of imaging
DeepHealth is a global leader in AI-powered health informatics for real-world settings. Our solutions address both clinical and operational challenges that arise in complex, high-volume care settings, streamlining the entire workflow to ease the burden on providers and enable a more seamless experience – for care teams and patients.
Book a demo
“AI is a complete game changer of population screening programs.”
Sham Sokka
Chief Operating and Technology Officer, DeepHealth
“The data that we now have from the Targeted Lung Health Checks is that 75% of the cancers we’re picking up are early stage, that’s stages one and two.”
Dr. Sophie Tisi
Respiratory Physician
“I’m working in symbiosis with the AI, and I have to genuinely say, hand on my heart, that AI has made me a better radiologist.”
Prof. Sam Hare
Consultant Chest Radiologist & CEO Health and Lung Health
Screening at scale
Discover how our AI-powered solutions are transforming healthcare by providing advanced imaging and data analytics to improve patient outcomes and operational efficiency.
Find out more
Improving cancer detection rates
76%
Of detected lung cancer found at earlier stages1
Improving staff experience
18%
Demonstrated increase in breast cancer detection rate2
Driving operational and clinical excellence
10%
Reduction in radiologists’ reporting time for scans3
Improving clinical excellence
42%
Faster interpretation of lung CT scans3
Learn more
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
Los Angeles, CA and Nashua, NH – April 15, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they have entered into a definitive merger agreement under which RadNet will acquire iCAD in an all stock transaction.
AI is transforming cancer detection – what’s next?
Artificial intelligence (AI) is transforming the fight against cancer by enabling faster and more accurate cancer detection. DeepHealth, a global leader in AI-powered health informatics, is pioneering new ways to advance cancer screening and broader imaging-based care, harnessing AI in an integrated, end-to-end approach to radically improve healthcare delivery.
RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
Somerville, MA, November 29, 2024 – DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo1, is now FDA-cleared to be compatible with GE HealthCare’s Senographe Pristina™ mammography systems.